Home / Knowledge Centre /

Overcoming Clinical Supply Chain Challenges in Investigator Initiated Studies

Investigator Initiated Studies (IIS) offer pharmaceutical sponsor companies the benefit of increasing product knowledge and expanding the medical use of their drug. However, managing these studies presents unique clinical supply chain challenges and can become a very complex process. In this webinar, Almac’s clinical supply experts address these challenges and provide insight into how to best manage investigator initiated clinical studies.

What will you gain from our webinar:

  • Best practices for addressing the potential challenges in ensuring IIS drug supply availability while, balancing cost and risk.
  • Insight into the current IIS landscape: the increase in scale and complexity of IIS programs.
  • Fundamentals of demand planning and forecasting of drug supply considerations at an individual study or program level.
  • Optimising pack design and labelling strategies for IIS.
  • Learn about IIS regulatory considerations.

Click here to discover more about Almac Clinical Services

View Resource

Please complete this form to view the Webinar

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies